Kisspeptin vs Oxytocin
Emerging vs FDA Approved
synergistic Both involved in reproduction; kisspeptin stimulates GnRH; oxytocin enhances arousal.
Molecular Data
Kisspeptin Oxytocin
Weight 1,213.42 Da (KP-10) / 6,087 Da (KP-54) 1,007.19 Da
Half-life ~4 minutes (KP-10), ~28-32 minutes (KP-54) 3-6 minutes
Chain 10-54 amino acids 9 amino acids
Type Neuropeptide family (RFamide) Cyclic nonapeptide
Key Benefits
Kisspeptin
01 Potent reproductive hormone stimulation (LH/FSH)
02 Restoration of natural testosterone production
03 Fertility enhancement
04 Sexual function support
05 Hypogonadism treatment potential
Oxytocin
01 FDA-approved for labor induction with precise dosing via IV
02 Immediate onset in obstetric settings
03 Established safety profile in clinical use
04 Researched for anxiety, PTSD, autism, sexual dysfunction
Dosing Protocols
Kisspeptin
100-200 mcg per injection / Single dose for testing, or 2-3 times weekly (NEVER daily - causes desensitization)
Gonadotropin stimulation 100-200mcg Single dose or 2-3x weekly
Fertility support 0.4-1.0 nmol/kg (50-150mcg) As directed by physician
Sexual function (clinical) 1 nmol/kg/h 75-minute IV infusion
Oxytocin
Intranasal: 20-24 IU; Injectable: 10-40 IU; Sublingual: 50-100 IU / As needed for social/sexual support, or 1-2x daily for anxiety/PTSD protocols; max 1 dose per 24hr for sexual function
Labor Induction 0.5-2 mU/min initial, titrate to 1-2 mU/min every 30-60 min Continuous IV infusion
Postpartum Hemorrhage Prevention 10 units IM or 10-40 units in IV solution Single dose after placental delivery
Side Effects
Kisspeptin
Minimal acute side effects reported
Potential mild cardiovascular effects
Oxytocin
Mild headache
Nasal irritation (intranasal)
Nausea or vomiting
Transient blood pressure changes
Contraindications
Not recommended during pregnancy or breastfeeding
Caution with cardiovascular disease history
Daily dosing causes receptor desensitization
Certain obstetric conditions (see prescribing info)
Pregnancy (without medical supervision)
Active sinus infection (intranasal)
Severe hyponatremia
Research Evidence
Kisspeptin Oxytocin
Status Emerging FDA Approved
References 4 studies 3 studies
FDA Approved No Yes
This comparison is for educational and research purposes only. Consult a healthcare professional before use.